These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 26177355)
1. The Expression of GDF-15 in the Human Vitreous in the Presence of Retinal Pathologies with an Inflammatory Component. Ilhan HD; Bilgin AB; Toylu A; Dogan ME; Apaydin KC Ocul Immunol Inflamm; 2016; 24(2):178-83. PubMed ID: 26177355 [TBL] [Abstract][Full Text] [Related]
2. A comparison of sex steroid concentration levels in the vitreous and serum of patients with vitreoretinal diseases. Nishikawa Y; Morishita S; Horie T; Fukumoto M; Sato T; Kida T; Oku H; Sugasawa J; Ikeda T; Nakamura K PLoS One; 2017; 12(7):e0180933. PubMed ID: 28704441 [TBL] [Abstract][Full Text] [Related]
3. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment. Ogata N; Tombran-Tink J; Nishikawa M; Nishimura T; Mitsuma Y; Sakamoto T; Matsumura M Am J Ophthalmol; 2001 Sep; 132(3):378-82. PubMed ID: 11530051 [TBL] [Abstract][Full Text] [Related]
5. Adrenomedullin and leptin levels in diabetic retinopathy and retinal diseases. Er H; Doğanay S; Ozerol E; Yürekli M Ophthalmologica; 2005; 219(2):107-11. PubMed ID: 15802936 [TBL] [Abstract][Full Text] [Related]
6. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy. Zheng B; Li T; Chen H; Xu X; Zheng Z Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923 [TBL] [Abstract][Full Text] [Related]
7. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Deng J; Wu DZ; Gao R Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655 [TBL] [Abstract][Full Text] [Related]
8. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy. Itakura H; Kishi S; Kotajima N; Murakami M Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550 [TBL] [Abstract][Full Text] [Related]
9. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of RAGE and its ligands in proliferative retinal disease. Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297 [TBL] [Abstract][Full Text] [Related]
12. Transscleral permeation of subtenon triamcinolone in different vitreoretinal diseases. Shen L; Mao J; Chen Y; Sun S; Han Y; Cheng L Ophthalmology; 2015 Mar; 122(3):649-51. PubMed ID: 25439434 [No Abstract] [Full Text] [Related]
13. Level of vitreous alpha-B crystallin in eyes with rhegmatogenous retinal detachment. Baba T; Oshitari T; Yamamoto S Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1251-4. PubMed ID: 25311653 [TBL] [Abstract][Full Text] [Related]
14. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy. Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy. Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J Am J Ophthalmol; 2000 May; 129(5):678-80. PubMed ID: 10844070 [TBL] [Abstract][Full Text] [Related]
16. Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy. Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J Ophthalmologica; 2001; 215(6):415-8. PubMed ID: 11741107 [TBL] [Abstract][Full Text] [Related]
17. Profiles of Inflammatory Cytokines in the Vitreous Fluid from Patients with Rhegmatogenous Retinal Detachment and Their Correlations with Clinical Features. Takahashi S; Adachi K; Suzuki Y; Maeno A; Nakazawa M Biomed Res Int; 2016; 2016():4256183. PubMed ID: 28074184 [No Abstract] [Full Text] [Related]
18. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy. Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657 [TBL] [Abstract][Full Text] [Related]
19. Measurement of activities in two different angiotensin II generating systems, chymase and angiotensin-converting enzyme, in the vitreous fluid of vitreoretinal diseases: a possible involvement of chymase in the pathogenesis of macular hole patients. Maruichi M; Oku H; Takai S; Muramatsu M; Sugiyama T; Imamura Y; Minami M; Ueki M; Satoh B; Sakaguchi M; Miyazaki M; Ikeda T Curr Eye Res; 2004; 29(4-5):321-5. PubMed ID: 15590479 [TBL] [Abstract][Full Text] [Related]
20. Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy. Pinna A; Emanueli C; Dore S; Salvo M; Madeddu P; Carta F Ophthalmologica; 2004; 218(4):260-3. PubMed ID: 15258415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]